Mach7 Technologies Signs Five-Year Subscription License Deal with US Not-for-Profit Health System; Shares Up 3%
MT Newswires Live
Dec 03, 2025
Mach7 Technologies (ASX:M7T) signed a five-year subscription license agreement with not-for-profit health system UnityPoint Health for its new Flamingo Architecture products, according to a Wednesday filing with the Australian bourse.
The subscription license is expected to initially contribute around AU$600,000 to the annual recurring revenue, growing up to AU$1 million, based on an increase in usage from a minimum of 1.5 million studies per year to an anticipated 3 million studies per year, the filing said.
Mach7 Technologies shares rose 3% in afternoon trade on Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.